This report provides an analysis of the Global Epilepsy Therapeutics industry for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030. The report analyses the Epilepsy Therapeutics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). ![Epilepsy Therapeutics Market]( "Epilepsy Therapeutics Market")
The Global Epilepsy Therapeutics market showcased growth at a CAGR of 3.97% during 2020-2023. The market was valued at USD 11.48 billion in 2023 which is expected to reach USD 15.81 billion in 2030.
The epilepsy therapeutics market is projected to experience sustained growth over the coming years, driven by increasing epilepsy prevalence, rising awareness, advancements in drug development, and greater access to healthcare across both developed and emerging markets.
Increasing diagnosis rates, greater awareness, and improved access to healthcare are contributing to rising epilepsy prevalence worldwide. Aging populations and the higher incidence of epilepsy in both the very young and elderly are further driving demand for effective therapeutics.
The global burden of epilepsy, affecting over 50 million people, continues to drive demand. Regions with increasing awareness and healthcare access, such as Latin America, are particularly contributing to growth as epilepsy is highly prevalent, especially in children.
High demand for paediatric epilepsy care has been observed due to rising incidence rates and population growth. There is a focus on making Anti-Epileptic Drugs more accessible in this region as awareness and diagnosis rates improve.
The Global Epilepsy Therapeutics market showcased growth at a CAGR of 3.97% during 2020-2023. The market was valued at USD 11.48 billion in 2023 which is expected to reach USD 15.81 billion in 2030.
The epilepsy therapeutics market is projected to experience sustained growth over the coming years, driven by increasing epilepsy prevalence, rising awareness, advancements in drug development, and greater access to healthcare across both developed and emerging markets.
Increasing diagnosis rates, greater awareness, and improved access to healthcare are contributing to rising epilepsy prevalence worldwide. Aging populations and the higher incidence of epilepsy in both the very young and elderly are further driving demand for effective therapeutics.
The global burden of epilepsy, affecting over 50 million people, continues to drive demand. Regions with increasing awareness and healthcare access, such as Latin America, are particularly contributing to growth as epilepsy is highly prevalent, especially in children.
High demand for paediatric epilepsy care has been observed due to rising incidence rates and population growth. There is a focus on making Anti-Epileptic Drugs more accessible in this region as awareness and diagnosis rates improve.
Scope of the Report
- The report analyses the Epilepsy Therapeutics Market by Value (USD Million).
- The report analyses the Epilepsy Therapeutics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
- The report presents the analysis of Epilepsy Therapeutics Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
- The report analyses the Epilepsy Therapeutics Market by Generation (First Generation, Second Generation, Third Generation).
- The report analyses the Epilepsy Therapeutics Market by Route of Administration (Oral, Intravenous).
- The report analyses the Epilepsy Therapeutics Market by Type (Branded, Generics).
- The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Generation, by Route of Administration and by Type.
- Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analyzed in the report include Novartis, Pfizer, GSK plc., Merck & Co., Inc., Johnson & Johnson, Sanofi, Teva Pharmaceuticals, Abbott Laboratories, Jazz Pharmaceuticals, Neurelis, Inc.
Table of Contents
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
2.1 Innovation in Drug Formulation
2.2 Telemedicine and Digital Health
2.2 Telemedicine and Digital Health
3. Epilepsy Therapeutics Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Epilepsy Therapeutics Market
3.2 Global Prevalence of Infectious Disease, 2019
3.3 Global Incidence of Infectious Disease, 2019
3.4 Major Epilepsy Drugs in Pipeline, 2024
3.5 Global Epilepsy Therapeutics Market: Dashboard
3.6 Global Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
3.7 Global Epilepsy Therapeutics Market: Market Value Assessment
3.8 Global Epilepsy Therapeutics Market Segmentation: by Generation
3.8.1 Global Epilepsy Therapeutics Market, by Generation Overview
3.8.2 Global Epilepsy Therapeutics Market Attractiveness Index, by Generation
3.8.3 Global Epilepsy Therapeutics Market Size, by First Generation, by Value, 2020H-2030F (USD Million & CAGR)
3.8.4 Global Epilepsy Therapeutics Market Size, by Second Generation, by Value, 2020H-2030F (USD Million & CAGR)
3.8.5 Global Epilepsy Therapeutics Market Size, by Third Generation, by Value, 2020H-2030F (USD Million & CAGR)
3.9 Global Epilepsy Therapeutics Market Segmentation: by Route of Administration
3.9.1 Global Epilepsy Therapeutics Market, by Route of Administration Overview
3.9.2 Global Epilepsy Therapeutics Market Attractiveness Index, by Route of Administration
3.9.3 Global Epilepsy Therapeutics Market Size, by Oral, by Value, 2020H-2030F (USD Million & CAGR)
3.9.4 Global Epilepsy Therapeutics Market Size, by Intravenous, by Value, 2020H-2030F (USD Million & CAGR)
3.10 Global Epilepsy Therapeutics Market Segmentation: by Type
3.10.1 Global Epilepsy Therapeutics Market, by Type Overview
3.10.2 Global Epilepsy Therapeutics Market Attractiveness Index, by Type
3.10.3 Global Epilepsy Therapeutics Market Size, by Branded, by Value, 2020H-2030F (USD Million & CAGR)
3.10.4 Global Epilepsy Therapeutics Market Size, by Generics, by Value, 2020H-2030F (USD Million & CAGR)
3.2 Global Prevalence of Infectious Disease, 2019
3.3 Global Incidence of Infectious Disease, 2019
3.4 Major Epilepsy Drugs in Pipeline, 2024
3.5 Global Epilepsy Therapeutics Market: Dashboard
3.6 Global Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
3.7 Global Epilepsy Therapeutics Market: Market Value Assessment
3.8 Global Epilepsy Therapeutics Market Segmentation: by Generation
3.8.1 Global Epilepsy Therapeutics Market, by Generation Overview
3.8.2 Global Epilepsy Therapeutics Market Attractiveness Index, by Generation
3.8.3 Global Epilepsy Therapeutics Market Size, by First Generation, by Value, 2020H-2030F (USD Million & CAGR)
3.8.4 Global Epilepsy Therapeutics Market Size, by Second Generation, by Value, 2020H-2030F (USD Million & CAGR)
3.8.5 Global Epilepsy Therapeutics Market Size, by Third Generation, by Value, 2020H-2030F (USD Million & CAGR)
3.9 Global Epilepsy Therapeutics Market Segmentation: by Route of Administration
3.9.1 Global Epilepsy Therapeutics Market, by Route of Administration Overview
3.9.2 Global Epilepsy Therapeutics Market Attractiveness Index, by Route of Administration
3.9.3 Global Epilepsy Therapeutics Market Size, by Oral, by Value, 2020H-2030F (USD Million & CAGR)
3.9.4 Global Epilepsy Therapeutics Market Size, by Intravenous, by Value, 2020H-2030F (USD Million & CAGR)
3.10 Global Epilepsy Therapeutics Market Segmentation: by Type
3.10.1 Global Epilepsy Therapeutics Market, by Type Overview
3.10.2 Global Epilepsy Therapeutics Market Attractiveness Index, by Type
3.10.3 Global Epilepsy Therapeutics Market Size, by Branded, by Value, 2020H-2030F (USD Million & CAGR)
3.10.4 Global Epilepsy Therapeutics Market Size, by Generics, by Value, 2020H-2030F (USD Million & CAGR)
4. Epilepsy Therapeutics Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
4.2 Regional Snapshot
5. Americas Epilepsy Therapeutics Market: Historic and Forecast
5.1 Americas Epilepsy Therapeutics Market: Snapshot
5.2 Americas Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.3 Americas Epilepsy Therapeutics Market: Key Factors
5.4 Americas Epilepsy Therapeutics Market: Segment Analysis
5.5 Americas Epilepsy Therapeutics Market Segmentation: by Generation
5.5.1 Americas Epilepsy Therapeutics Market, by Generation Overview
5.5.2 Americas Epilepsy Therapeutics Market Size, by First Generation, by Value, 2020H-2030F (USD Million & CAGR)
5.5.3 Americas Epilepsy Therapeutics Market Size, by Second Generation, by Value, 2020H-2030F (USD Million & CAGR)
5.5.4 Americas Epilepsy Therapeutics Market Size, by Third Generation, by Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Epilepsy Therapeutics Market Segmentation: by Route of Administration
5.6.1 Americas Epilepsy Therapeutics Market, by Route of Administration Overview
5.6.2 Americas Epilepsy Therapeutics Market Size, by Oral, by Value, 2020H-2030F (USD Million & CAGR)
5.6.3 Americas Epilepsy Therapeutics Market Size, by Intravenous, by Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Epilepsy Therapeutics Market Segmentation: by Type
5.7.1 Americas Epilepsy Therapeutics Market, by Type Overview
5.7.2 Americas Epilepsy Therapeutics Market Size, by Branded, by Value, 2020H-2030F (USD Million & CAGR)
5.7.3 Americas Epilepsy Therapeutics Market Size, by Generics, by Value, 2020H-2030F (USD Million & CAGR)
5.8 Americas Epilepsy Therapeutics Market Segmentation: by Country
5.8.1 Americas Epilepsy Therapeutics Market, by Country Overview
5.8.2 United States Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.2.1 United States Epilepsy Therapeutics Market, by Generation
5.8.2.2 United States Epilepsy Therapeutics Market, by Route of Administration
5.8.2.3 United States Epilepsy Therapeutics Market, by Type
5.8.3 Canada Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.3.1 Canada Epilepsy Therapeutics Market, by Generation
5.8.3.2 Canada Epilepsy Therapeutics Market, by Route of Administration
5.8.3.3 Canada Epilepsy Therapeutics Market, by Type
5.8.4 Rest of Americas Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.4.1 Rest of Americas Epilepsy Therapeutics Market, by Generation
5.8.4.2 Rest of Americas Epilepsy Therapeutics Market, by Route of Administration
5.8.4.3 Rest of Americas Epilepsy Therapeutics Market, by Type
5.2 Americas Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.3 Americas Epilepsy Therapeutics Market: Key Factors
5.4 Americas Epilepsy Therapeutics Market: Segment Analysis
5.5 Americas Epilepsy Therapeutics Market Segmentation: by Generation
5.5.1 Americas Epilepsy Therapeutics Market, by Generation Overview
5.5.2 Americas Epilepsy Therapeutics Market Size, by First Generation, by Value, 2020H-2030F (USD Million & CAGR)
5.5.3 Americas Epilepsy Therapeutics Market Size, by Second Generation, by Value, 2020H-2030F (USD Million & CAGR)
5.5.4 Americas Epilepsy Therapeutics Market Size, by Third Generation, by Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Epilepsy Therapeutics Market Segmentation: by Route of Administration
5.6.1 Americas Epilepsy Therapeutics Market, by Route of Administration Overview
5.6.2 Americas Epilepsy Therapeutics Market Size, by Oral, by Value, 2020H-2030F (USD Million & CAGR)
5.6.3 Americas Epilepsy Therapeutics Market Size, by Intravenous, by Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Epilepsy Therapeutics Market Segmentation: by Type
5.7.1 Americas Epilepsy Therapeutics Market, by Type Overview
5.7.2 Americas Epilepsy Therapeutics Market Size, by Branded, by Value, 2020H-2030F (USD Million & CAGR)
5.7.3 Americas Epilepsy Therapeutics Market Size, by Generics, by Value, 2020H-2030F (USD Million & CAGR)
5.8 Americas Epilepsy Therapeutics Market Segmentation: by Country
5.8.1 Americas Epilepsy Therapeutics Market, by Country Overview
5.8.2 United States Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.2.1 United States Epilepsy Therapeutics Market, by Generation
5.8.2.2 United States Epilepsy Therapeutics Market, by Route of Administration
5.8.2.3 United States Epilepsy Therapeutics Market, by Type
5.8.3 Canada Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.3.1 Canada Epilepsy Therapeutics Market, by Generation
5.8.3.2 Canada Epilepsy Therapeutics Market, by Route of Administration
5.8.3.3 Canada Epilepsy Therapeutics Market, by Type
5.8.4 Rest of Americas Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.4.1 Rest of Americas Epilepsy Therapeutics Market, by Generation
5.8.4.2 Rest of Americas Epilepsy Therapeutics Market, by Route of Administration
5.8.4.3 Rest of Americas Epilepsy Therapeutics Market, by Type
6. Europe Epilepsy Therapeutics Market: Historic and Forecast
6.1 Europe Epilepsy Therapeutics Market: Snapshot
6.2 Europe Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.3 Europe Epilepsy Therapeutics Market: Key Factors
6.4 Europe Epilepsy Therapeutics Market: Segment Analysis
6.5 Europe Epilepsy Therapeutics Market Segmentation: by Generation
6.5.1 Europe Epilepsy Therapeutics Market, by Generation Overview
6.5.2 Europe Epilepsy Therapeutics Market Size, by First Generation, by Value, 2020H-2030F (USD Million & CAGR)
6.5.3 Europe Epilepsy Therapeutics Market Size, by Second Generation, by Value, 2020H-2030F (USD Million & CAGR)
6.5.4 Europe Epilepsy Therapeutics Market Size, by Third Generation, by Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Epilepsy Therapeutics Market Segmentation: by Route of Administration
6.6.1 Europe Epilepsy Therapeutics Market, by Route of Administration Overview
6.6.2 Europe Epilepsy Therapeutics Market Size, by Oral, by Value, 2020H-2030F (USD Million & CAGR)
6.6.3 Europe Epilepsy Therapeutics Market Size, by Intravenous, by Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Epilepsy Therapeutics Market Segmentation: by Type
6.7.1 Europe Epilepsy Therapeutics Market, by Type Overview
6.7.2 Europe Epilepsy Therapeutics Market Size, by Branded, by Value, 2020H-2030F (USD Million & CAGR)
6.7.3 Europe Epilepsy Therapeutics Market Size, by Generics, by Value, 2020H-2030F (USD Million & CAGR)
6.8 Europe Epilepsy Therapeutics Market Segmentation: by Country
6.8.1 Europe Epilepsy Therapeutics Market, by Country Overview
6.8.2 Germany Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.2.1 Germany Epilepsy Therapeutics Market, by Generation
6.8.2.2 Germany Epilepsy Therapeutics Market, by Route of Administration
6.8.2.3 Germany Epilepsy Therapeutics Market, by Type
6.8.3 United Kingdom Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.3.1 United Kingdom Epilepsy Therapeutics Market, by Generation
6.8.3.2 United Kingdom Epilepsy Therapeutics Market, by Route of Administration
6.8.3.3 United Kingdom Epilepsy Therapeutics Market, by Type
6.8.4 France Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.4.1 France Epilepsy Therapeutics Market, by Generation
6.8.4.2 France Epilepsy Therapeutics Market, by Route of Administration
6.8.4.3 France Epilepsy Therapeutics Market, by Type
6.8.5 Italy Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.5.1 Italy Epilepsy Therapeutics Market, by Generation
6.8.5.2 Italy Epilepsy Therapeutics Market, by Route of Administration
6.8.5.3 Italy Epilepsy Therapeutics Market, by Type
6.8.6 Spain Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.6.1 Spain Epilepsy Therapeutics Market, by Generation
6.8.6.2 Spain Epilepsy Therapeutics Market, by Route of Administration
6.8.6.3 Spain Epilepsy Therapeutics Market, by Type
6.8.7 Rest of Europe Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.7.1 Rest of Europe Epilepsy Therapeutics Market, by Generation
6.8.7.2 Rest of Europe Epilepsy Therapeutics Market, by Route of Administration
6.8.7.3 Rest of Europe Epilepsy Therapeutics Market, by Type
6.2 Europe Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.3 Europe Epilepsy Therapeutics Market: Key Factors
6.4 Europe Epilepsy Therapeutics Market: Segment Analysis
6.5 Europe Epilepsy Therapeutics Market Segmentation: by Generation
6.5.1 Europe Epilepsy Therapeutics Market, by Generation Overview
6.5.2 Europe Epilepsy Therapeutics Market Size, by First Generation, by Value, 2020H-2030F (USD Million & CAGR)
6.5.3 Europe Epilepsy Therapeutics Market Size, by Second Generation, by Value, 2020H-2030F (USD Million & CAGR)
6.5.4 Europe Epilepsy Therapeutics Market Size, by Third Generation, by Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Epilepsy Therapeutics Market Segmentation: by Route of Administration
6.6.1 Europe Epilepsy Therapeutics Market, by Route of Administration Overview
6.6.2 Europe Epilepsy Therapeutics Market Size, by Oral, by Value, 2020H-2030F (USD Million & CAGR)
6.6.3 Europe Epilepsy Therapeutics Market Size, by Intravenous, by Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Epilepsy Therapeutics Market Segmentation: by Type
6.7.1 Europe Epilepsy Therapeutics Market, by Type Overview
6.7.2 Europe Epilepsy Therapeutics Market Size, by Branded, by Value, 2020H-2030F (USD Million & CAGR)
6.7.3 Europe Epilepsy Therapeutics Market Size, by Generics, by Value, 2020H-2030F (USD Million & CAGR)
6.8 Europe Epilepsy Therapeutics Market Segmentation: by Country
6.8.1 Europe Epilepsy Therapeutics Market, by Country Overview
6.8.2 Germany Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.2.1 Germany Epilepsy Therapeutics Market, by Generation
6.8.2.2 Germany Epilepsy Therapeutics Market, by Route of Administration
6.8.2.3 Germany Epilepsy Therapeutics Market, by Type
6.8.3 United Kingdom Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.3.1 United Kingdom Epilepsy Therapeutics Market, by Generation
6.8.3.2 United Kingdom Epilepsy Therapeutics Market, by Route of Administration
6.8.3.3 United Kingdom Epilepsy Therapeutics Market, by Type
6.8.4 France Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.4.1 France Epilepsy Therapeutics Market, by Generation
6.8.4.2 France Epilepsy Therapeutics Market, by Route of Administration
6.8.4.3 France Epilepsy Therapeutics Market, by Type
6.8.5 Italy Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.5.1 Italy Epilepsy Therapeutics Market, by Generation
6.8.5.2 Italy Epilepsy Therapeutics Market, by Route of Administration
6.8.5.3 Italy Epilepsy Therapeutics Market, by Type
6.8.6 Spain Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.6.1 Spain Epilepsy Therapeutics Market, by Generation
6.8.6.2 Spain Epilepsy Therapeutics Market, by Route of Administration
6.8.6.3 Spain Epilepsy Therapeutics Market, by Type
6.8.7 Rest of Europe Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.7.1 Rest of Europe Epilepsy Therapeutics Market, by Generation
6.8.7.2 Rest of Europe Epilepsy Therapeutics Market, by Route of Administration
6.8.7.3 Rest of Europe Epilepsy Therapeutics Market, by Type
7. Asia-Pacific Epilepsy Therapeutics Market: Historic and Forecast
7.1 Asia-Pacific Epilepsy Therapeutics Market: Snapshot
7.2 Asia-Pacific Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.3 Asia-Pacific Epilepsy Therapeutics Market: Key Factors
7.4 Asia-Pacific Epilepsy Therapeutics Market: Segment Analysis
7.5 Asia-Pacific Epilepsy Therapeutics Market Segmentation: by Generation
7.5.1 Asia-Pacific Epilepsy Therapeutics Market, by Generation Overview
7.5.2 Asia-Pacific Epilepsy Therapeutics Market Size, by First Generation, by Value, 2020H-2030F (USD Million & CAGR)
7.5.3 Asia-Pacific Epilepsy Therapeutics Market Size, by Second Generation, by Value, 2020H-2030F (USD Million & CAGR)
7.5.4 Asia-Pacific Epilepsy Therapeutics Market Size, by Third Generation, by Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia-Pacific Epilepsy Therapeutics Market Segmentation: by Route of Administration
7.6.1 Asia-Pacific Epilepsy Therapeutics Market, by Route of Administration Overview
7.6.2 Asia-Pacific Epilepsy Therapeutics Market Size, by Oral, by Value, 2020H-2030F (USD Million & CAGR)
7.6.3 Asia-Pacific Epilepsy Therapeutics Market Size, by Intravenous, by Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia-Pacific Epilepsy Therapeutics Market Segmentation: by Type
7.7.1 Asia-Pacific Epilepsy Therapeutics Market, by Type Overview
7.7.2 Asia-Pacific Epilepsy Therapeutics Market Size, by Branded, by Value, 2020H-2030F (USD Million & CAGR)
7.7.3 Asia-Pacific Epilepsy Therapeutics Market Size, by Generics, by Value, 2020H-2030F (USD Million & CAGR)
7.8 Asia-Pacific Epilepsy Therapeutics Market Segmentation: by Country
7.8.1 Asia-Pacific Epilepsy Therapeutics Market, by Country Overview
7.8.2 China Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.2.1 China Epilepsy Therapeutics Market, by Generation
7.8.2.2 China Epilepsy Therapeutics Market, by Route of Administration
7.8.2.3 China Epilepsy Therapeutics Market, by Type
7.8.3 Japan Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.3.1 Japan Epilepsy Therapeutics Market, by Generation
7.8.3.2 Japan Epilepsy Therapeutics Market, by Route of Administration
7.8.3.3 Japan Epilepsy Therapeutics Market, by Type
7.8.4 India Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.4.1 India Epilepsy Therapeutics Market, by Generation
7.8.4.2 India Epilepsy Therapeutics Market, by Route of Administration
7.8.4.3 India Epilepsy Therapeutics Market, by Type
7.8.5 Rest of Asia-Pacific Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.5.1 Rest of Asia-Pacific Epilepsy Therapeutics Market, by Generation
7.8.5.2 Rest of Asia-Pacific Epilepsy Therapeutics Market, by Route of Administration
7.8.5.3 Rest of Asia-Pacific Epilepsy Therapeutics Market, by Type
7.2 Asia-Pacific Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.3 Asia-Pacific Epilepsy Therapeutics Market: Key Factors
7.4 Asia-Pacific Epilepsy Therapeutics Market: Segment Analysis
7.5 Asia-Pacific Epilepsy Therapeutics Market Segmentation: by Generation
7.5.1 Asia-Pacific Epilepsy Therapeutics Market, by Generation Overview
7.5.2 Asia-Pacific Epilepsy Therapeutics Market Size, by First Generation, by Value, 2020H-2030F (USD Million & CAGR)
7.5.3 Asia-Pacific Epilepsy Therapeutics Market Size, by Second Generation, by Value, 2020H-2030F (USD Million & CAGR)
7.5.4 Asia-Pacific Epilepsy Therapeutics Market Size, by Third Generation, by Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia-Pacific Epilepsy Therapeutics Market Segmentation: by Route of Administration
7.6.1 Asia-Pacific Epilepsy Therapeutics Market, by Route of Administration Overview
7.6.2 Asia-Pacific Epilepsy Therapeutics Market Size, by Oral, by Value, 2020H-2030F (USD Million & CAGR)
7.6.3 Asia-Pacific Epilepsy Therapeutics Market Size, by Intravenous, by Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia-Pacific Epilepsy Therapeutics Market Segmentation: by Type
7.7.1 Asia-Pacific Epilepsy Therapeutics Market, by Type Overview
7.7.2 Asia-Pacific Epilepsy Therapeutics Market Size, by Branded, by Value, 2020H-2030F (USD Million & CAGR)
7.7.3 Asia-Pacific Epilepsy Therapeutics Market Size, by Generics, by Value, 2020H-2030F (USD Million & CAGR)
7.8 Asia-Pacific Epilepsy Therapeutics Market Segmentation: by Country
7.8.1 Asia-Pacific Epilepsy Therapeutics Market, by Country Overview
7.8.2 China Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.2.1 China Epilepsy Therapeutics Market, by Generation
7.8.2.2 China Epilepsy Therapeutics Market, by Route of Administration
7.8.2.3 China Epilepsy Therapeutics Market, by Type
7.8.3 Japan Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.3.1 Japan Epilepsy Therapeutics Market, by Generation
7.8.3.2 Japan Epilepsy Therapeutics Market, by Route of Administration
7.8.3.3 Japan Epilepsy Therapeutics Market, by Type
7.8.4 India Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.4.1 India Epilepsy Therapeutics Market, by Generation
7.8.4.2 India Epilepsy Therapeutics Market, by Route of Administration
7.8.4.3 India Epilepsy Therapeutics Market, by Type
7.8.5 Rest of Asia-Pacific Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.5.1 Rest of Asia-Pacific Epilepsy Therapeutics Market, by Generation
7.8.5.2 Rest of Asia-Pacific Epilepsy Therapeutics Market, by Route of Administration
7.8.5.3 Rest of Asia-Pacific Epilepsy Therapeutics Market, by Type
8. Middle East and Africa Epilepsy Therapeutics Market: Historic and Forecast
8.1 Middle East and Africa Epilepsy Therapeutics Market: Snapshot
8.2 Middle East and Africa Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.3 Middle East and Africa Epilepsy Therapeutics Market: Key Factors
8.4 Middle East and Africa Epilepsy Therapeutics Market: Segment Analysis
8.5 Middle East and Africa Epilepsy Therapeutics Market Segmentation: by Generation
8.5.1 Middle East and Africa Epilepsy Therapeutics Market, by Generation Overview
8.5.2 Middle East and Africa Epilepsy Therapeutics Market Size, by First Generation, by Value, 2020H-2030F (USD Million & CAGR)
8.5.3 Middle East and Africa Epilepsy Therapeutics Market Size, by Second Generation, by Value, 2020H-2030F (USD Million & CAGR)
8.5.4 Middle East and Africa Epilepsy Therapeutics Market Size, by Third Generation, by Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East and Africa Epilepsy Therapeutics Market Segmentation: by Route of Administration
8.6.1 Middle East and Africa Epilepsy Therapeutics Market, by Route of Administration Overview
8.6.2 Middle East and Africa Epilepsy Therapeutics Market Size, by Oral, by Value, 2020H-2030F (USD Million & CAGR)
8.6.3 Middle East and Africa Epilepsy Therapeutics Market Size, by Intravenous, by Value, 2020H-2030F (USD Million & CAGR)
8.7 Middle East and Africa Epilepsy Therapeutics Market Segmentation: by Type
8.7.1 Middle East and Africa Epilepsy Therapeutics Market, by Type Overview
8.7.2 Middle East and Africa Epilepsy Therapeutics Market Size, by Branded, by Value, 2020H-2030F (USD Million & CAGR)
8.7.3 Middle East and Africa Epilepsy Therapeutics Market Size, by Generics, by Value, 2020H-2030F (USD Million & CAGR)
8.2 Middle East and Africa Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.3 Middle East and Africa Epilepsy Therapeutics Market: Key Factors
8.4 Middle East and Africa Epilepsy Therapeutics Market: Segment Analysis
8.5 Middle East and Africa Epilepsy Therapeutics Market Segmentation: by Generation
8.5.1 Middle East and Africa Epilepsy Therapeutics Market, by Generation Overview
8.5.2 Middle East and Africa Epilepsy Therapeutics Market Size, by First Generation, by Value, 2020H-2030F (USD Million & CAGR)
8.5.3 Middle East and Africa Epilepsy Therapeutics Market Size, by Second Generation, by Value, 2020H-2030F (USD Million & CAGR)
8.5.4 Middle East and Africa Epilepsy Therapeutics Market Size, by Third Generation, by Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East and Africa Epilepsy Therapeutics Market Segmentation: by Route of Administration
8.6.1 Middle East and Africa Epilepsy Therapeutics Market, by Route of Administration Overview
8.6.2 Middle East and Africa Epilepsy Therapeutics Market Size, by Oral, by Value, 2020H-2030F (USD Million & CAGR)
8.6.3 Middle East and Africa Epilepsy Therapeutics Market Size, by Intravenous, by Value, 2020H-2030F (USD Million & CAGR)
8.7 Middle East and Africa Epilepsy Therapeutics Market Segmentation: by Type
8.7.1 Middle East and Africa Epilepsy Therapeutics Market, by Type Overview
8.7.2 Middle East and Africa Epilepsy Therapeutics Market Size, by Branded, by Value, 2020H-2030F (USD Million & CAGR)
8.7.3 Middle East and Africa Epilepsy Therapeutics Market Size, by Generics, by Value, 2020H-2030F (USD Million & CAGR)
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Epilepsy Therapeutics Market
9.2 Drivers
9.3 Restraints
9.4 Trends
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Epilepsy Therapeutics Market
11.4 Company Profiles
11.4.1 Novartis
11.4.2 Pfizer
11.4.3 GSK plc.
11.4.4 Merck & Co., Inc.
11.4.5 Johnson & Johnson
11.4.6 Sanofi
11.4.7 Teva Pharmaceuticals
11.4.8 Abbott Laboratories
11.4.9 Jazz Pharmaceuticals
11.4.10 Neurelis, Inc.
11.2 Market Position Matrix
11.3 Market Share Analysis of Epilepsy Therapeutics Market
11.4 Company Profiles
11.4.1 Novartis
11.4.2 Pfizer
11.4.3 GSK plc.
11.4.4 Merck & Co., Inc.
11.4.5 Johnson & Johnson
11.4.6 Sanofi
11.4.7 Teva Pharmaceuticals
11.4.8 Abbott Laboratories
11.4.9 Jazz Pharmaceuticals
11.4.10 Neurelis, Inc.
List of Figures
Figure 1: Global Prevalence of Idiopathic Epilepsy
Figure 2: Global Incidence of Idiopathic Epilepsy
Figure 3: Epilepsy Therapeutics Market Size, by Value, 2020-2023 (USD Million)
Figure 4: Epilepsy Therapeutics Market Size, by Value, 2024-2030 (USD Million)
Figure 5: Epilepsy Therapeutics Market Share, by Type, 2023 (%)
Figure 6: Market Attractiveness Analysis of Epilepsy Therapeutics Market, by Generation (2025-2030)
Figure 7: Epilepsy Therapeutics Market Size, by First Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 8: Epilepsy Therapeutics Market Absolute Opportunity, by First Generation, 2020-2030 (USD Million)
Figure 9: Epilepsy Therapeutics Market Size, by Second Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 10: Epilepsy Therapeutics Market Absolute Opportunity, by Second Generation, 2020-2030 (USD Million)
Figure 11: Epilepsy Therapeutics Market Size, by Third Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 12: Epilepsy Therapeutics Market Absolute Opportunity, by Third Generation, 2020-2030 (USD Million)
Figure 13: Market Attractiveness Analysis of Epilepsy Therapeutics Market, by Route of Administration (2025-2030)
Figure 14: Epilepsy Therapeutics Market Size, by Oral, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 15: Epilepsy Therapeutics Market Absolute Opportunity, by Oral, 2020-2030 (USD Million)
Figure 16: Epilepsy Therapeutics Market Size, by Intravenous, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 17: Epilepsy Therapeutics Market Absolute Opportunity, by Intravenous, 2020-2030 (USD Million)
Figure 18: Market Attractiveness Analysis of Epilepsy Therapeutics Market, by Type (2025-2030)
Figure 19: Epilepsy Therapeutics Market Size, by Branded, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 20: Epilepsy Therapeutics Market Absolute Opportunity, by Branded, 2020-2030 (USD Million)
Figure 21: Epilepsy Therapeutics Market Size, by Generics, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 22: Epilepsy Therapeutics Market Absolute Opportunity, by Generics, 2020-2030 (USD Million)
Figure 23: Americas Epilepsy Therapeutics Market Size, by Value, 2020H-2030F (USD Million)
Figure 24: Americas Epilepsy Therapeutics Market Share, by Type, 2023 (%)
Figure 25: Americas Epilepsy Therapeutics Market, by First Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 26: Americas Epilepsy Therapeutics Market, by Second Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 27: Americas Epilepsy Therapeutics Market, by Third Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 28: Americas Epilepsy Therapeutics Market, by Oral, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 29: Americas Epilepsy Therapeutics Market, by Intravenous, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 30: Americas Epilepsy Therapeutics Market, by Branded, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 31: Americas Epilepsy Therapeutics Market, by Generics, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 32: United States Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 33: United States Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 34: United States Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 35: United States Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 36: United States Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 37: Canada Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 38: Canada Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 39: Canada Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 40: Canada Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 41: Canada Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 42: Rest of Americas Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 43: Rest of Americas Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 44: Rest of Americas Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 45: Rest of Americas Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 46: Rest of Americas Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 47: Europe Epilepsy Therapeutics Market Size, by Value, 2020H-2030F (USD Million)
Figure 48: Europe Epilepsy Therapeutics Market Share, by Type, 2023 (%)
Figure 49: Europe Epilepsy Therapeutics Market, by First Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 50: Europe Epilepsy Therapeutics Market, by Second Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 51: Europe Epilepsy Therapeutics Market, by Third Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 52: Europe Epilepsy Therapeutics Market, by Oral, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 53: Europe Epilepsy Therapeutics Market, by Intravenous, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 54: Europe Epilepsy Therapeutics Market, by Branded, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 55: Europe Epilepsy Therapeutics Market, by Generics, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 56: Germany Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 57: Germany Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 58: Germany Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 59: Germany Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 60: Germany Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 61: United Kingdom Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 62: United Kingdom Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 63: United Kingdom Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 64: United Kingdom Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 65: United Kingdom Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 66: France Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 67: France Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 68: France Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 69: France Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 70: France Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 71: Italy Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 72: Italy Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 73: Italy Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 74: Italy Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 75: Italy Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 76: Spain Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 77: Spain Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 78: Spain Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 79: Spain Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 80: Spain Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 81: Rest of Europe Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 82: Rest of Europe Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 83: Rest of Europe Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 84: Rest of Europe Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 85: Rest of Europe Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 86: Asia-Pacific Epilepsy Therapeutics Market Size, by Value, 2020H-2030F (USD Million)
Figure 87: Asia-Pacific Epilepsy Therapeutics Market Share, by Type, 2023 (%)
Figure 88: Asia-Pacific Epilepsy Therapeutics Market, by First Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 89: Asia-Pacific Epilepsy Therapeutics Market, by Second Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 90: Asia-Pacific Epilepsy Therapeutics Market, by Third Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 91: Asia-Pacific Epilepsy Therapeutics Market, by Oral, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 92: Asia-Pacific Epilepsy Therapeutics Market, by Intravenous, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 93: Asia-Pacific Epilepsy Therapeutics Market, by Branded, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 94: Asia-Pacific Epilepsy Therapeutics Market, by Generics, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 95: China Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 96: China Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 97: China Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 98: China Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 99: China Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 100: Japan Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 101: Japan Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 102: Japan Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 103: Japan Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 104: Japan Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 105: India Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 106: India Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 107: India Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 108: India Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 109: India Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 110: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 111: Rest of Asia-Pacific Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 112: Rest of Asia-Pacific Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 113: Rest of Asia-Pacific Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 114: Rest of Asia-Pacific Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 115: Middle East and Africa Epilepsy Therapeutics Market Size, by Value, 2020H-2030F (USD Million)
Figure 116: Middle East and Africa Epilepsy Therapeutics Market Share, by Type, 2023 (%)
Figure 117: Middle East and Africa Epilepsy Therapeutics Market, by First Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 118: Middle East and Africa Epilepsy Therapeutics Market, by Second Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 119: Middle East and Africa Epilepsy Therapeutics Market, by Third Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 120: Middle East and Africa Epilepsy Therapeutics Market, by Oral, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 121: Middle East and Africa Epilepsy Therapeutics Market, by Intravenous, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 122: Middle East and Africa Epilepsy Therapeutics Market, by Branded, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 123: Middle East and Africa Epilepsy Therapeutics Market, by Generics, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 124: Market Share of Prominent Companies of Epilepsy Therapeutics Market, 2023 (%)
Figure 125: Novartis Revenues, 2021-2023 (USD Million)
Figure 126: Novartis Revenues, by Geographic Segments, 2023 (%)
Figure 127: Novartis Revenue , by Business Segments, 2023 (%)
Figure 128: Pfizer Revenues, 2021-2023 (USD Million)
Figure 129: Pfizer Revenues, by Business Segments, 2023 (%)
Figure 130: Pfizer Inc. Revenue , by Geographical Segments, 2023 (%)
Figure 131: GSK PLC Revenue, 2020-2022 (USD Million)
Figure 132: GSK PLC Revenue , by Business Segments, 2023 (%)
Figure 133: GSK PLC Revenue, by Geography Segment, 2023 (%)
Figure 134: Merck & Co., Inc. Revenues, 2021-2023 (USD Million)
Figure 135: Merck & Co., Inc. Revenues, by Geographic Segments, 2023 (%)
Figure 136: Merck & Co., Inc. Revenue , by Business Segments, 2023 (%)
Figure 137: Johnson & Johnson Revenue, 2021-2023 (USD Million)
Figure 138: Johnson & Johnson Revenue, by Geographical Segments, 2023 (%)
Figure 139: Johnson & Johnson Revenue, by Business Segments, 2023 (%)
Figure 140: Sanofi Revenues, 2021-2023 (USD Million)
Figure 141: Sanofi Revenues, by Geographic Segments, 2023 (%)
Figure 142: Sanofi Revenue, by Business Segments, 2023 (%)
Figure 143: Teva Pharmaceuticals Revenues, 2021-2023 (USD Million)
Figure 144: Teva Pharmaceuticals Revenue, by Geographical Segments, 2023 (%)
Figure 145: Abbott Laboratories Revenues, 2021-2023 (USD Million)
Figure 146: Abbott Laboratories Revenues, by Geographic Segments, 2023 (%)
Figure 147: Abbott Laboratories Revenue , by Business Segments, 2023 (%)
Figure 148: Jazz Pharmaceuticals Revenues, 2021-2023 (USD Th)
Figure 149: Jazz Pharmaceuticals Revenues, by Geographic Segments, 2023 (%)
Figure 150: Jazz Pharmaceuticals Revenue , by Business Segments, 2023 (%)
Figure 2: Global Incidence of Idiopathic Epilepsy
Figure 3: Epilepsy Therapeutics Market Size, by Value, 2020-2023 (USD Million)
Figure 4: Epilepsy Therapeutics Market Size, by Value, 2024-2030 (USD Million)
Figure 5: Epilepsy Therapeutics Market Share, by Type, 2023 (%)
Figure 6: Market Attractiveness Analysis of Epilepsy Therapeutics Market, by Generation (2025-2030)
Figure 7: Epilepsy Therapeutics Market Size, by First Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 8: Epilepsy Therapeutics Market Absolute Opportunity, by First Generation, 2020-2030 (USD Million)
Figure 9: Epilepsy Therapeutics Market Size, by Second Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 10: Epilepsy Therapeutics Market Absolute Opportunity, by Second Generation, 2020-2030 (USD Million)
Figure 11: Epilepsy Therapeutics Market Size, by Third Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 12: Epilepsy Therapeutics Market Absolute Opportunity, by Third Generation, 2020-2030 (USD Million)
Figure 13: Market Attractiveness Analysis of Epilepsy Therapeutics Market, by Route of Administration (2025-2030)
Figure 14: Epilepsy Therapeutics Market Size, by Oral, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 15: Epilepsy Therapeutics Market Absolute Opportunity, by Oral, 2020-2030 (USD Million)
Figure 16: Epilepsy Therapeutics Market Size, by Intravenous, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 17: Epilepsy Therapeutics Market Absolute Opportunity, by Intravenous, 2020-2030 (USD Million)
Figure 18: Market Attractiveness Analysis of Epilepsy Therapeutics Market, by Type (2025-2030)
Figure 19: Epilepsy Therapeutics Market Size, by Branded, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 20: Epilepsy Therapeutics Market Absolute Opportunity, by Branded, 2020-2030 (USD Million)
Figure 21: Epilepsy Therapeutics Market Size, by Generics, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 22: Epilepsy Therapeutics Market Absolute Opportunity, by Generics, 2020-2030 (USD Million)
Figure 23: Americas Epilepsy Therapeutics Market Size, by Value, 2020H-2030F (USD Million)
Figure 24: Americas Epilepsy Therapeutics Market Share, by Type, 2023 (%)
Figure 25: Americas Epilepsy Therapeutics Market, by First Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 26: Americas Epilepsy Therapeutics Market, by Second Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 27: Americas Epilepsy Therapeutics Market, by Third Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 28: Americas Epilepsy Therapeutics Market, by Oral, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 29: Americas Epilepsy Therapeutics Market, by Intravenous, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 30: Americas Epilepsy Therapeutics Market, by Branded, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 31: Americas Epilepsy Therapeutics Market, by Generics, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 32: United States Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 33: United States Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 34: United States Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 35: United States Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 36: United States Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 37: Canada Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 38: Canada Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 39: Canada Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 40: Canada Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 41: Canada Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 42: Rest of Americas Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 43: Rest of Americas Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 44: Rest of Americas Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 45: Rest of Americas Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 46: Rest of Americas Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 47: Europe Epilepsy Therapeutics Market Size, by Value, 2020H-2030F (USD Million)
Figure 48: Europe Epilepsy Therapeutics Market Share, by Type, 2023 (%)
Figure 49: Europe Epilepsy Therapeutics Market, by First Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 50: Europe Epilepsy Therapeutics Market, by Second Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 51: Europe Epilepsy Therapeutics Market, by Third Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 52: Europe Epilepsy Therapeutics Market, by Oral, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 53: Europe Epilepsy Therapeutics Market, by Intravenous, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 54: Europe Epilepsy Therapeutics Market, by Branded, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 55: Europe Epilepsy Therapeutics Market, by Generics, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 56: Germany Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 57: Germany Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 58: Germany Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 59: Germany Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 60: Germany Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 61: United Kingdom Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 62: United Kingdom Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 63: United Kingdom Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 64: United Kingdom Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 65: United Kingdom Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 66: France Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 67: France Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 68: France Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 69: France Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 70: France Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 71: Italy Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 72: Italy Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 73: Italy Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 74: Italy Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 75: Italy Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 76: Spain Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 77: Spain Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 78: Spain Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 79: Spain Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 80: Spain Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 81: Rest of Europe Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 82: Rest of Europe Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 83: Rest of Europe Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 84: Rest of Europe Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 85: Rest of Europe Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 86: Asia-Pacific Epilepsy Therapeutics Market Size, by Value, 2020H-2030F (USD Million)
Figure 87: Asia-Pacific Epilepsy Therapeutics Market Share, by Type, 2023 (%)
Figure 88: Asia-Pacific Epilepsy Therapeutics Market, by First Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 89: Asia-Pacific Epilepsy Therapeutics Market, by Second Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 90: Asia-Pacific Epilepsy Therapeutics Market, by Third Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 91: Asia-Pacific Epilepsy Therapeutics Market, by Oral, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 92: Asia-Pacific Epilepsy Therapeutics Market, by Intravenous, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 93: Asia-Pacific Epilepsy Therapeutics Market, by Branded, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 94: Asia-Pacific Epilepsy Therapeutics Market, by Generics, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 95: China Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 96: China Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 97: China Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 98: China Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 99: China Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 100: Japan Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 101: Japan Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 102: Japan Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 103: Japan Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 104: Japan Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 105: India Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 106: India Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 107: India Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 108: India Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 109: India Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 110: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Value, 2020-2030 (USD Millions & CAGR)
Figure 111: Rest of Asia-Pacific Epilepsy Therapeutics Market Value, by Route of Administration, 2023 (USD Million)
Figure 112: Rest of Asia-Pacific Epilepsy Therapeutics Market Share, by Generation, by Value, 2023 (%)
Figure 113: Rest of Asia-Pacific Epilepsy Therapeutics Market Share, by Route of Administration, by Value, 2023 (%)
Figure 114: Rest of Asia-Pacific Epilepsy Therapeutics Market Share, by Type, by Value, 2023 (%)
Figure 115: Middle East and Africa Epilepsy Therapeutics Market Size, by Value, 2020H-2030F (USD Million)
Figure 116: Middle East and Africa Epilepsy Therapeutics Market Share, by Type, 2023 (%)
Figure 117: Middle East and Africa Epilepsy Therapeutics Market, by First Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 118: Middle East and Africa Epilepsy Therapeutics Market, by Second Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 119: Middle East and Africa Epilepsy Therapeutics Market, by Third Generation, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 120: Middle East and Africa Epilepsy Therapeutics Market, by Oral, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 121: Middle East and Africa Epilepsy Therapeutics Market, by Intravenous, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 122: Middle East and Africa Epilepsy Therapeutics Market, by Branded, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 123: Middle East and Africa Epilepsy Therapeutics Market, by Generics, by Value, 2020H-2030F (USD Millions & CAGR)
Figure 124: Market Share of Prominent Companies of Epilepsy Therapeutics Market, 2023 (%)
Figure 125: Novartis Revenues, 2021-2023 (USD Million)
Figure 126: Novartis Revenues, by Geographic Segments, 2023 (%)
Figure 127: Novartis Revenue , by Business Segments, 2023 (%)
Figure 128: Pfizer Revenues, 2021-2023 (USD Million)
Figure 129: Pfizer Revenues, by Business Segments, 2023 (%)
Figure 130: Pfizer Inc. Revenue , by Geographical Segments, 2023 (%)
Figure 131: GSK PLC Revenue, 2020-2022 (USD Million)
Figure 132: GSK PLC Revenue , by Business Segments, 2023 (%)
Figure 133: GSK PLC Revenue, by Geography Segment, 2023 (%)
Figure 134: Merck & Co., Inc. Revenues, 2021-2023 (USD Million)
Figure 135: Merck & Co., Inc. Revenues, by Geographic Segments, 2023 (%)
Figure 136: Merck & Co., Inc. Revenue , by Business Segments, 2023 (%)
Figure 137: Johnson & Johnson Revenue, 2021-2023 (USD Million)
Figure 138: Johnson & Johnson Revenue, by Geographical Segments, 2023 (%)
Figure 139: Johnson & Johnson Revenue, by Business Segments, 2023 (%)
Figure 140: Sanofi Revenues, 2021-2023 (USD Million)
Figure 141: Sanofi Revenues, by Geographic Segments, 2023 (%)
Figure 142: Sanofi Revenue, by Business Segments, 2023 (%)
Figure 143: Teva Pharmaceuticals Revenues, 2021-2023 (USD Million)
Figure 144: Teva Pharmaceuticals Revenue, by Geographical Segments, 2023 (%)
Figure 145: Abbott Laboratories Revenues, 2021-2023 (USD Million)
Figure 146: Abbott Laboratories Revenues, by Geographic Segments, 2023 (%)
Figure 147: Abbott Laboratories Revenue , by Business Segments, 2023 (%)
Figure 148: Jazz Pharmaceuticals Revenues, 2021-2023 (USD Th)
Figure 149: Jazz Pharmaceuticals Revenues, by Geographic Segments, 2023 (%)
Figure 150: Jazz Pharmaceuticals Revenue , by Business Segments, 2023 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, by Region
Table A2: Major Epilepsy Drugs in Pipeline, 2024
Table A3: United States Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A4: United States Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A5: United States Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A6: United States Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A7: United States Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A8: United States Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A9: Canada Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A10: Canada Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A11: Canada Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A12: Canada Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A13: Canada Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A14: Canada Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A15: Rest of Americas Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A16: Rest of Americas Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A17: Rest of Americas Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A18: Rest of Americas Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A19: Rest of Americas Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A20: Rest of Americas Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A21: Germany Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A22: Germany Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A23: Germany Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A24: Germany Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A25: Germany Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A26: Germany Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A27: United Kingdom Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A28: United Kingdom Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A29: United Kingdom Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A30: United Kingdom Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A31: United Kingdom Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A32: United Kingdom Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A33: France Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A34: France Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A35: France Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A36: France Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A37: France Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A38: France Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A39: Italy Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A40: Italy Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A41: Italy Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A42: Italy Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A43: Italy Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A44: Italy Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A45: Spain Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A46: Spain Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A47: Spain Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A48: Spain Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A49: Spain Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A50: Spain Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A51: Rest of Europe Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A52: Rest of Europe Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A53: Rest of Europe Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A54: Rest of Europe Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A55: Rest of Europe Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A56: Rest of Europe Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A57: China Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A58: China Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A59: China Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A60: China Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A61: China Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A62: China Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A63: Japan Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A64: Japan Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A65: Japan Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A66: Japan Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A67: Japan Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A68: Japan Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A69: India Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A70: India Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A71: India Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A72: India Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A73: India Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A74: India Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A75: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A76: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A77: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A78: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A79: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A80: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A81: Novartis Key Financials, 2021-2023
Table A82: Pfizer Key Financials, 2021-2023
Table A83: GSK PLC Key Company Financials, 2021-2023
Table A84: Merck & Co., Inc. Key Financials, 2021-2023
Table A85: Johnson & Johnson Key Company Financials, 2021-2023
Table A86: Sanofi Key Financials, 2021-2023
Table A87: Teva Pharmaceuticals Key Financials, 2021-2023
Table A88: Abbott Laboratories Key Financials, 2021-2023
Table A89: Jazz Pharmaceuticals Key Financials, 2021-2023
Table A2: Major Epilepsy Drugs in Pipeline, 2024
Table A3: United States Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A4: United States Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A5: United States Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A6: United States Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A7: United States Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A8: United States Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A9: Canada Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A10: Canada Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A11: Canada Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A12: Canada Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A13: Canada Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A14: Canada Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A15: Rest of Americas Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A16: Rest of Americas Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A17: Rest of Americas Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A18: Rest of Americas Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A19: Rest of Americas Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A20: Rest of Americas Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A21: Germany Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A22: Germany Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A23: Germany Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A24: Germany Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A25: Germany Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A26: Germany Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A27: United Kingdom Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A28: United Kingdom Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A29: United Kingdom Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A30: United Kingdom Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A31: United Kingdom Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A32: United Kingdom Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A33: France Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A34: France Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A35: France Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A36: France Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A37: France Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A38: France Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A39: Italy Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A40: Italy Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A41: Italy Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A42: Italy Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A43: Italy Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A44: Italy Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A45: Spain Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A46: Spain Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A47: Spain Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A48: Spain Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A49: Spain Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A50: Spain Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A51: Rest of Europe Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A52: Rest of Europe Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A53: Rest of Europe Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A54: Rest of Europe Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A55: Rest of Europe Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A56: Rest of Europe Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A57: China Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A58: China Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A59: China Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A60: China Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A61: China Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A62: China Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A63: Japan Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A64: Japan Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A65: Japan Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A66: Japan Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A67: Japan Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A68: Japan Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A69: India Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A70: India Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A71: India Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A72: India Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A73: India Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A74: India Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A75: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Generation, by Value, 2020-2023 (USD Million)
Table A76: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Generation, by Value, 2025-2030 (USD Million)
Table A77: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Route of Administration, by Value, 2020-2023 (USD Million)
Table A78: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Route of Administration, by Value, 2025-2030 (USD Million)
Table A79: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Type, by Value, 2020-2023 (USD Million)
Table A80: Rest of Asia-Pacific Epilepsy Therapeutics Market, by Type, by Value, 2025-2030 (USD Million)
Table A81: Novartis Key Financials, 2021-2023
Table A82: Pfizer Key Financials, 2021-2023
Table A83: GSK PLC Key Company Financials, 2021-2023
Table A84: Merck & Co., Inc. Key Financials, 2021-2023
Table A85: Johnson & Johnson Key Company Financials, 2021-2023
Table A86: Sanofi Key Financials, 2021-2023
Table A87: Teva Pharmaceuticals Key Financials, 2021-2023
Table A88: Abbott Laboratories Key Financials, 2021-2023
Table A89: Jazz Pharmaceuticals Key Financials, 2021-2023
Companies Mentioned
- Novartis
- Pfizer
- GSK plc.
- Merck & Co., Inc.
- Johnson & Johnson
- Sanofi
- Teva Pharmaceuticals
- Abbott Laboratories
- Jazz Pharmaceuticals
- Neurelis, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 242 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 11.48 Billion |
| Forecasted Market Value ( USD | $ 15.81 Billion |
| Compound Annual Growth Rate | 3.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
